FUTR BIO is a Brazilian biotechnology startup founded in 2022 with the goal of developing next generation mRNA vaccines. Their proprietary mRNA vaccine technology, which incorporates natural UTRs and molecular boosters, aims to provide superior immune responses against infectious diseases and cancer. The company's slogan "We develop next generation mRNA vaccines to prevent and cure diseases such as infections and cancer" succinctly captures their mission. In February 2022, FUTR BIO secured Pre Seed Round investment from Vesper Ventures SA, signifying early investor confidence in their innovative approach to combating diseases through mRNA vaccines.
No recent news or press coverage available for FUTR BIO.